Related references
Note: Only part of the references are listed.Baseline Radiomic Signature to Estimate Overall Survival in Patients With NSCLC
Laurent Dercle et al.
JOURNAL OF THORACIC ONCOLOGY (2023)
An imaging signature to predict outcome in metastatic colorectal cancer using routine computed tomography scans
Laurent Dercle et al.
EUROPEAN JOURNAL OF CANCER (2022)
Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis
Laurent Dercle et al.
JAMA ONCOLOGY (2022)
AACR Cancer Disparities Progress Report 2022
Patrick A. Williams et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)
Radiomics-based nomogram as predictive model for prognosis of hepatocellular carcinoma with portal vein tumor thrombosis receiving radiotherapy
Yu-Ming Huang et al.
FRONTIERS IN ONCOLOGY (2022)
Cancer health disparities in racial/ethnic minorities in the United States
Valentina A. Zavala et al.
BRITISH JOURNAL OF CANCER (2021)
Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives
Madhurima R. Chetan et al.
EUROPEAN RADIOLOGY (2021)
Development and Validation of a Computed Tomography-Based Radiomics Signature to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
Wei Wang et al.
JAMA NETWORK OPEN (2021)
Colorectal cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway
Laurent Dercle et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Identification of Non-Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics
Laurent Dercle et al.
CLINICAL CANCER RESEARCH (2020)
Vol-PACT: A Foundation for the NIH Public-Private Partnership That Supports Sharing of Clinical Trial Data for the Development of Improved Imaging Biomarkers in Oncology
Laurent Derck et al.
JCO CLINICAL CANCER INFORMATICS (2018)
Radiomic-Based Pathological Response Prediction from Primary Tumors and Lymph Nodes in NSCLC
Thibaud P. Coroller et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Charting the Future of Cancer Health Disparities Research: A Position Statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute
Blase N. Polite et al.
CANCER RESEARCH (2017)
A meta-analysis of MSI frequency and race in colorectal cancer
Hassan Ashktorab et al.
ONCOTARGET (2016)
Novel recurrently mutated genes in African American colon cancers
Kishore Guda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer
J. Y. Douillard et al.
ANNALS OF ONCOLOGY (2014)
Disparities in survival improvement for metastatic colorectal cancer by race/ethnicity and age in the United States
Helmneh M. Sineshaw et al.
CANCER CAUSES & CONTROL (2014)
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial
Josep Tabernero et al.
EUROPEAN JOURNAL OF CANCER (2014)
Interventions to Improve Care Related to Colorectal Cancer Among Racial and Ethnic Minorities: A Systematic Review
Keith Naylor et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2012)
Determinants of racial/ethnic colorectal cancer screening disparities
Anthony F. Jerant et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992-2001
Rosemary D. Cress et al.
CANCER (2006)
Patients' perceptions of quality of care for colorectal cancer by race, ethnicity, and language
JZ Ayanian et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)